| Bioactivity | Miocamycin (Midecamycin acetate) is a derivative of midecamycin (HY-B1908), a macrolide antibiotic that can be isolated from a culture broth of Streptomyces mycarofaciens. Miocamycin has antibacterial properties[1]. |
| In Vivo | Miocamycin (口服，每日一次，持续 26 周) 对雄性和雌性大鼠 (Wistar，SPF，5 周龄)的最大无毒剂量水平为 250 mg/kg。 |
| Name | Miocamycin |
| CAS | 55881-07-7 |
| Formula | C45H71NO17 |
| Molar Mass | 898.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. TOXICOLOGICAL STUDIES ON A NEW MACROLIDE ANTIBIOTIC, MIDECAMYCIN ACETATE (MIOCAMYCIN). July 1984. Volume 37 Issue 7 Pages 1355-1375. |